MIRAJ PHARMA LIMITED
Registered number: 07326838
Balance Sheet
as at 30 September 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 4 36,645 49,531
Current assets
Stocks 40,057 49,713
Debtors 5 - 60,948
Cash at bank and in hand 118,089 85,109
158,146 195,770
Creditors: amounts falling due within one year 6 220,708 119,941
Net current assets 378,854 315,711
Net assets 415,499 365,242
Capital and reserves
Called up share capital 100 100
Profit and loss account 415,399 365,142
Shareholder's funds 415,499 365,242
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Miraj Nanu MIAH
Director
Approved by the board on 20 June 2025
MIRAJ PHARMA LIMITED
Notes to the Accounts
for the year ended 30 September 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Fixtures, fittings, tools and equipment 20%
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 9 15
3 Intangible fixed assets £
Goodwill:
Cost
At 1 October 2023 772,998
At 30 September 2024 772,998
Amortisation
At 1 October 2023 772,998
At 30 September 2024 772,998
Net book value
At 30 September 2024 -
Goodwill is being written off in equal annual instalments over its estimated economic life of 10 years.
4 Tangible fixed assets
Plant and machinery etc Motor vehicles Total
£ £ £
Cost
At 1 October 2023 49,346 44,089 93,435
At 30 September 2024 49,346 44,089 93,435
Depreciation
At 1 October 2023 29,006 14,898 43,904
Charge for the year 4,068 8,818 12,886
At 30 September 2024 33,074 23,716 56,790
Net book value
At 30 September 2024 16,272 20,373 36,645
At 30 September 2023 20,340 29,191 49,531
5 Debtors 2024 2023
£ £
Trade debtors - 60,948
6 Creditors: amounts falling due within one year 2024 2023
£ £
Trade creditors 106,902 125,543
Nest 821 797
Corporation tax 16,400 25,697
Other taxes and social security costs (448,015) (381,490)
Other creditors 103,184 109,512
(220,708) (119,941)
7 Other information
MIRAJ PHARMA LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
40 Lord Avenue
Ilford
IG5 0HN
8 Depreciation
Company's policy is to depreciate Plant & Machinery @20% using reducing balance method and Motor Vehicle @20% using staright line method.
MIRAJ PHARMA LIMITED 07326838 false 2023-10-01 2024-09-30 2024-09-30 VT Final Accounts July 2024 Miraj Nanu MIAH No description of principal activity 07326838 2022-10-01 2023-09-30 07326838 core:WithinOneYear 2023-09-30 07326838 core:ShareCapital 2023-09-30 07326838 core:RetainedEarningsAccumulatedLosses 2023-09-30 07326838 2023-10-01 2024-09-30 07326838 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 07326838 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 07326838 bus:Director40 2023-10-01 2024-09-30 07326838 1 2023-10-01 2024-09-30 07326838 2 2023-10-01 2024-09-30 07326838 core:PlantMachinery 2023-10-01 2024-09-30 07326838 core:Vehicles 2023-10-01 2024-09-30 07326838 countries:England 2023-10-01 2024-09-30 07326838 bus:FRS102 2023-10-01 2024-09-30 07326838 bus:FilletedAccounts 2023-10-01 2024-09-30 07326838 2024-09-30 07326838 core:WithinOneYear 2024-09-30 07326838 core:ShareCapital 2024-09-30 07326838 core:RetainedEarningsAccumulatedLosses 2024-09-30 07326838 core:Goodwill 2024-09-30 07326838 core:PlantMachinery 2024-09-30 07326838 core:Vehicles 2024-09-30 07326838 2023-09-30 07326838 core:Goodwill 2023-09-30 07326838 core:PlantMachinery 2023-09-30 07326838 core:Vehicles 2023-09-30 iso4217:GBP xbrli:pure